Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by BILLMINERon Dec 23, 2016 4:11pm

140 Views

Post# 25641440

RE:RE:RE:RE:Rat animal model: 2003 Photofrin data versus TLD-1433 data

Cytochrome sounds like one arrogant individual. The last data (report) that Bencro posted was relatively easy to understand, even to this lay geologist. No need for arrogance like that. Merry Xmas to all

Bullboard Posts

Canopy Growth nears adjusted EBITDA profitability in Q2 2025